Real-time enrollment status for this primary vitreoretinal lymphoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 3:46 PM UTC
| NCT Number | NCT07402876 |
| Recruiting Status | Recruiting |
| Condition | Primary Vitreoretinal Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 20 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Aldeyra Therapeutics, Inc. |
| Last Updated on CT.gov | February 11, 2026 (Feb 11, 2026) |
As of July 13, 2026: Clinical trial NCT07402876 is currently recruiting participants. This clinical trial study for primary vitreoretinal lymphoma is actively seeking new participants at 1 location across the United States. The study is sponsored by Aldeyra Therapeutics, Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07402876 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07402876 was last updated Feb 11, 2026 (February 11, 2026). HelloStudys verifies this status automatically.